Increased expression of endothelial nitric oxide synthase and caveolin-1 in the aorta of rats with isoproterenol-induced cardiac hypertrophy

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 12, 2006, Pages 1245-1250

  Krenek, P ^a   Klimas, J ^a   Kroslakova, M ^a   Gazova, A ^a   Plandorova, J ^a   Kucerova, D ^a   Fecenkova, A ^a   Svec, P ^a   Kyselovic, J ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Cardiac hypertrophy; Caveolin; Endothelial nitric oxide synthase; Endothelium dependent relaxation; Isoproterenol; Nitric oxide

Indexed keywords

ACETYLCHOLINE; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOPRENALINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG SENSITIVITY; EX VIVO STUDY; HEART LEFT VENTRICLE; HEART RATE; HEART RIGHT VENTRICLE; HEART VENTRICLE HYPERTROPHY; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PRESSURE; CARDIOMEGALY; CAVEOLIN 1; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HEART VENTRICLES; ISOPROTERENOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; ORGAN SIZE; RATS; RATS, WISTAR; UP-REGULATION; VASODILATION; VASODILATOR AGENTS;

EID: 34248177967     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-073     Document Type: Article

References (36)

1. Bouloumie, A., Bauersachs, J., Linz, W., Scholkens, B.A., Wiemer, G., Fleming, I., and Busse, R. 1997. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension, 30: 934-941.
2. Carvalho, M.H., Scivoletto, R., Fortes, Z.B., Nigro, D., and Cordellini, S. 1987. Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats: role of the endothelium. J. Hypertens. 5: 377-382. doi:10.1097/00004872-198706000-00019.
3. Davel, A.P., Kawamoto, E.M., Scavone, C., Vassallo, D.V., and Rossoni, L.V. 2006. Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation. Br. J. Pharmacol. 148: 629-639. doi:10.1038/sj.bjp. 0706749.
4. Dessy, C., Moniotte, S., Ghisdal, P., Havaux, X., Noirhomme, P., and Balligand, J.L. 2004. Endothelial β3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation, 110: 948-954. doi:10.1161/01.CIR. 0000139331.85766.AR
5. Dessy, C., Saliez, J., Ghisdal, P., Daneau, G., Lobysheva, I.I., Frerart, F., et al. 2005. Endothelial β3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation P-blocker nebivolol. Circulation, 112: 1198-1205. doi:10.1161/CIRCULATIONAHA.104.532960.
6. Drexler, H., Hayoz, D., Munzel, T., Hornig, B., Just, H., Brunner, H.R., and Zelis, R. 1992. Endothelial function in chronic congestive heart failure. Am. J. Cardiol. 69: 1596-1601. doi:10. 1016/0002-9149(92)90710-G.
7. Dudzinski, D.M., Igarashi, J., Greif, D., and Michel, T. 2006. The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol. 46: 235-276. doi:10. 1146/annurev.pharmtox.44.101802. 121844.
8. Falsetti, H.L., Carroll, R.J., Swope, R.D., and Chen, C.J. 1983. Turbulent blood flow in the ascending aorta of dogs. Cardiovasc. Res. 17: 427-436.
9. Feron, O., Belhassen, L., Kobzik, L., Smith, T.W., Kelly, R.A., and Michel, T. 1996. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271: 22810-22814.
10. Feron, O., Dessy, C., Moniotte, S., Desager, J.P., and Balligand, J.L. 1999. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J. Clin. Invest. 103: 897-905.
11. Feron, O., Dessy, C., Desager, J.P., and Balligand, J.L. 2001. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation, 103: 113-118.
12. Ferro, A., Queen, L.R., Priest, R.M., Xu, B., Ritter, J.M., Poston, L., and Ward, J.P. 1999. Activation of nitric oxide synthase by P2-adrenoceptors in human umbilical vein endothelium in vitro. Br. J. Pharmacol. 126: 1872-1880. doi:10.1038/sj.bjp.0702512.
13. Ferro, A., Coash, M., Yamamoto, T., Rob, J., Ji, Y., and Queen, L. 2004. Nitric oxide-dependent P2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br. J. Pharmacol. 143: 397-403. doi:10.1038/sj.bjp. 0705933.
14. Grimm, D., Eisner, D., Schunkert, H., Pfeifer, M., Griese, D., Bruckschlegel, G., et al. 1998. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc. Res. 37: 91-100. doi:10.1016/S0008-6363(97)00212-5.
15. Howell, R.E., Albelda, S.M., Daise, M.L., and Levine, E.M. 1988. Characterization of P-adrenergic receptors in cultured human and bovine endothelial cells. J. Appl. Physiol. 65: 1251-1257.
16. Iaccarino, G., Ciccarelli, M., Sorriento, D., Galasso, G., Campanile, A., Santulli, G., et al. 2005. Ischemic neoangiogenesis enhanced by β2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ. Res. 97: 1182-1189. doi:10.1161/01.RES. 0000191541.06788.bb.
17. Jayachandran, M., Hayashi, T., Sumi, D., Thakur, N.K., Kano, H., Ignarro, L.J., and Iguchi, A. 2001. Up-regulation of endothelial nitric oxide synthase through P(2)-adrenergic receptor-the role of a β-blocker with NO-releasing action. Biochem. Biophys. Res. Commun. 280: 589-594. doi:10.1006/bbrc. 2000.4177.
18. Krenek, P., Salomone, S., Kyselovic, J., Wibo, M., Morel, N., and Godfraind, T. 2001. Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats. Hypertension, 37: 1124-1128.
19. Lam, C.F., Peterson, T.E., Richardson, D.M., Croatt, A.J., d'Uscio, L.V., Nath, K.A., and Katusic, Z.S. 2006a. Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am. J. Physiol. Heart Circ. Physiol. 290: H786-H793.
20. Lam, T.Y., Seto, S.W., Lau, Y.M., Au, L.S., Kwan, Y.W., Ngai, S.M., and Tsui, K.W. 2006b. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice. Eur. J. Pharmacol. 546: 134-141. doi:10.1016/j.ejphar.2006.07.003.
21. Luscher, T.F., Raij, L., and Vanhoutte, P.M. 1987. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension, 9: 157-163.
22. Mayhan, W.G., Faraci, F.M., and Heistad, D.D. 1987. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am. J. Physiol. 253: H1435-H1440.
23. 2+-calmodulin and caveolin. J. Biol. Chem. 272: 15583-15586. doi:10.1074/jbc.272.25. 15583.
24. Molenaar, P., Malta, E., Jones, C.R., Buxton, B.F., and Summers, R.J. 1988. Autoradiographic localization and function of P-adrenoceptors on the human internal mammary artery and saphenous vein. Br. J. Pharmacol. 95: 225-233.
25. Nishida, K., Harrison, D.G., Navas, J.P., Fisher, A.A., Dockery, S.P., Uematsu, M., et al. 1992. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90: 2092-2096.
26. Oka, N., Asai, K., Kudej, R.K., Edwards, J.G., Toya, Y., Schwencke, C., et al. 1997. Downregulation of caveolin by chronic β-adrenergic receptor stimulation in mice. Am. J. Physiol. 273: C1957-C1962.
27. Perticone, F., Maio, R., Ceravolo, R., Cosco, C., Cloro, C., and Mattioli, P.L. 1999. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients. Circulation, 99: 1991-1996.
28. Pueyo, M.E., Chen, Y., D'Angelo, G., and Michel, J.B. 1998. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. Exp. Cell Res. 238: 354-358. doi:10.1006/excr.1997.3864.
29. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K., and Harrison, D.G. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97: 1916-1923.
30. Rembold, C.M., and Chen, X.L. 1998. Mechanisms responsible for forskolin-induced relaxation of rat tail artery. Hypertension, 31: 872-877.
31. Sciacqua, A., Scozzafava, A., Pujia, A., Maio, R., Borrello, F., Andreozzi, F., et al. 2005. Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension. Eur. Heart J. 26: 921-927. doi:10. 1093/eurheartj/ehi112.
32. Shimokawa, H., Yasutake, H., Fujii, K., Owada, M.K., Nakaike, R., Fukumoto, Y., et al. 1996. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J. Cardiovasc. Pharmacol. 28: 703-711. doi:10.1097/00005344-199611000-00014.
33. Steinberg, S.F., Jaffe, E.A., and Bilezikian, J.P. 1984. Endothelial cells contain β adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 325: 310-313. doi:10.1007/BF00504374.
34. Sun, R.J., Muller, S., Stoltz, J.F., and Wang, X. 2002. Shear stress induces caveolin-1 translocation in cultured endothelial cells. Eur. Biophys. J. 30: 605-611.
35. Szabo, J., Csaky, L., and Szegi, J. 1975. Experimental cardiac hypertrophy induced by isoproterenol in the rat. Acta Physiol. Acad. Sci. Hung. 46: 281-285.
36. Trochu, J.N., Leblais, V., Rautureau, Y., Beverelli, F., Le Marec, H., Berdeaux, A., and Gauthier, C. 1999. β3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br. J. Pharmacol. 128: 69-76. doi:10.1038/sj.bjp.0702797.